Research article summary (published 14 Sep 2009):

Prostanoid receptor subtypes: new targets for OAB drugs?

Full Abstract

No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Andersson, Karl-Erik (KE);

Journal and publication information

Publication Type: Editorial

Journal: The Journal of urology (J Urol), published in United States. (Language: eng)

Reference: 2009-Nov; vol 182 (issue 5) : pp 2099-100

Dates: Created 2009/10/12; Completed 2009/10/30;

PMID: 19758658, status: MEDLINE (last retrieval date: 10/30/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Humans Receptors, Prostaglandin - classification; drug effects

Receptors, Thromboxane - classification; drug effects Urinary Bladder, Overactive - drug therapy

Associated Chemicals: Receptors, Prostaglandin (0) ; Receptors, Thromboxane (0)

Related articles

These are the highest related articles currently in the database:

• Thromboxane A2/prostaglandin H2 receptors in streptozotocin-induced diabetes: effects of insulin therapy in the rat. 29 Apr 1993
• Dibenz[b,e]oxepin derivatives: novel antiallergic agents possessing thromboxane A2 and histamine H1 dual antagonizing activity. 1. 3 Feb 1993
• Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine. 28 Mar 1995
• Advances in anti-inflammatory therapy. 27 Feb 1994
• Blood pressure effects of thromboxane A2 blockade in spontaneously hypertensive rats. 30 Oct 1993
• Actions of the E2-isoprostane, 8-ISO-PGE2, on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor. 29 Sep 1994
• Halothane and isoflurane preferentially inhibit prostanoid-induced vasoconstriction of rat aorta. 29 Sep 1994
• Thromboxane synthase inhibition and thromboxane/endoperoxide receptor antagonism in a chronic canine model of coronary thrombosis. 30 Dec 1986
• Prolongation of experimental cardiac allograft survival with thromboxane-related drugs. 30 Jul 1985
• Preservation of ischemic myocardial tissue with an antagonist of vasoconstrictor eicosanoids. 29 Nov 1984

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.